Jilin Asymchem Pharmaceuticals Co., Ltd. – FDA Inspection, Apr 30, 2026

Record Details

This FDA Inspection record concerns Jilin Asymchem Pharmaceuticals Co., Ltd., with an inspection on April 30, 2026, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Jilin Asymchem Pharmaceuticals Co., Ltd.
Inspection Date: April 30, 2026
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Joseph A. Piechocki (Issuing Officer)

View Company Profile

ID · cc285145-9a46-4074-b831-8f8243e25b29

Inspection Facts

Inspection number: 1319018
FDA center: Human Drugs
Outcome: Form 483 issued, view the record

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Jilin Asymchem Pharmaceuticals Co., Ltd.

FDA Inspection

Jilin Asymchem Pharmaceuticals Co., Ltd.April 30, 2026

Jilin Asymchem Pharmaceuticals Co., Ltd. – FDA Inspection, Apr 30, 2026

Record Details

This FDA Inspection record concerns Jilin Asymchem Pharmaceuticals Co., Ltd., with an inspection on April 30, 2026, issued by the Office of Inspections and Investigations, covering human drugs.